Clinical Trial: Vitamin K2 (35) (MK-7) Reduces Dark Eye Circles: a Mechanistic and Human Efficacy Study

U.S., Oct. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07881367) titled 'Vitamin K2 (35) (MK-7) Reduces Dark Eye Circles: a Mechanistic and Human Efficacy Study' on Oct. 12.

Brief Summary: The goal of this clinical trial is to learn if an eye cream containing 0.05% Vitamin K2 (35) (MK-7) works to reduce vascular-type dark eye circles in women aged 20-60 years. It will also learn about the mechanism of action of MK-7 through laboratory studies. The main questions it aims to answer are:

Does the MK-7 eye cream improve under-eye skin color (lightness (L*) and individual typology angle (ITAdeg)) after 4 weeks of use?

Does the MK-7 eye cream reduce under-eye melanin content after 4 weeks of use?

Does the M...